AdaptHealth Corp. (NASDAQ:AHCO) Receives Average Rating of “Hold” from Brokerages

AdaptHealth Corp. (NASDAQ:AHCO) has been assigned a consensus rating of “Hold” from the five brokerages that are covering the company, Marketbeat reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have assigned a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $10.70.

Several brokerages recently issued reports on AHCO. Royal Bank of Canada reaffirmed an “outperform” rating and set a $13.00 target price on shares of AdaptHealth in a research report on Monday, August 12th. Robert W. Baird decreased their price objective on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a research report on Wednesday.

Insider Activity

In other AdaptHealth news, COO Shaw Rietkerk sold 25,000 shares of the firm’s stock in a transaction that occurred on Friday, September 20th. The shares were sold at an average price of $11.24, for a total transaction of $281,000.00. Following the completion of the transaction, the chief operating officer now directly owns 212,611 shares of the company’s stock, valued at approximately $2,389,747.64. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other AdaptHealth news, COO Shaw Rietkerk sold 25,000 shares of the stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $11.24, for a total transaction of $281,000.00. Following the sale, the chief operating officer now directly owns 212,611 shares of the company’s stock, valued at approximately $2,389,747.64. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director David Solomon Williams III sold 4,000 shares of the business’s stock in a transaction dated Thursday, August 29th. The shares were sold at an average price of $11.26, for a total value of $45,040.00. Following the completion of the transaction, the director now directly owns 36,899 shares of the company’s stock, valued at approximately $415,482.74. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 4.43% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Boston Partners purchased a new position in shares of AdaptHealth during the 1st quarter valued at approximately $693,000. Russell Investments Group Ltd. acquired a new position in shares of AdaptHealth during the 1st quarter worth about $2,242,000. Hillsdale Investment Management Inc. acquired a new position in shares of AdaptHealth during the 1st quarter worth about $4,240,000. First Eagle Investment Management LLC raised its position in shares of AdaptHealth by 18.2% during the 1st quarter. First Eagle Investment Management LLC now owns 594,951 shares of the company’s stock worth $6,848,000 after purchasing an additional 91,772 shares during the last quarter. Finally, Vanguard Group Inc. lifted its stake in AdaptHealth by 8.9% in the 1st quarter. Vanguard Group Inc. now owns 10,017,722 shares of the company’s stock valued at $115,304,000 after buying an additional 818,241 shares in the last quarter. Hedge funds and other institutional investors own 82.67% of the company’s stock.

AdaptHealth Trading Down 9.6 %

AHCO opened at $9.18 on Wednesday. The company has a current ratio of 1.15, a quick ratio of 0.94 and a debt-to-equity ratio of 1.38. The firm has a market cap of $1.23 billion, a price-to-earnings ratio of -1.76, a PEG ratio of 1.63 and a beta of 1.11. AdaptHealth has a 12 month low of $6.37 and a 12 month high of $11.90. The stock has a fifty day moving average price of $10.76 and a 200-day moving average price of $10.44.

AdaptHealth (NASDAQ:AHCO) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.15 earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.02). The firm had revenue of $805.90 million during the quarter, compared to the consensus estimate of $809.32 million. AdaptHealth had a negative net margin of 21.20% and a positive return on equity of 9.58%. The firm’s quarterly revenue was up .2% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.19 earnings per share. As a group, equities research analysts anticipate that AdaptHealth will post 0.87 earnings per share for the current fiscal year.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.